Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): James N Kirkpatrick , Susan E Wiegers , J Eduardo Rame , et al Added: 3 years ago
There are at least five million patients with heart failure (HF) in the US, 5% of whom are considered end-stage.1 Mechanical circulatory support (MCS) in the form of ventricular assist devices (VADs) is becoming an increasingly important option for these patients. Previously reserved for rescuing patients in the throes of refractory cardiogenic shock, MCS is now a mainstay of end-stage heart… View more

Imaging & Diagnostics
Author(s): RJ Kanter Added: 3 years ago
Introduction Compared with patients with structurally normal hearts, there is an even greater need to suppress pathologic tachycardias in patients with congenital heart disease. The decrease in diastolic filling time and potential loss of atrioventricular (AV) synchrony are more poorly tolerated in these patients, proportionate to the degree of underlying systolic and diastolic dysfunction… View more

Heterogeneous Populations
Sanjay Sharma
ProfSharma qualified in the UK in 1989 and was appointed Consultant Cardiologist and Physician at University Hospital Lewisham. In 2006, he took up the post of Director of Heart Muscle Diseases at Kings College London and was promoted to Professor of Cardiology at St George’s University of London in 2010. He is medical director for Virgin London Marathon, consultant cardiologist for the CRY… View more
Andrew D’Silva
Dr Andrew D’Silva graduated from Royal Free and University College Medical School in 2007 with distinction, having also completed an intercalated BSc degree in Molecular Medicine, achieving first class honours and placement on the Dean’s List. Dr D’Silva spent his Foundation years working in his home county of Essex, later returning to London where he attained membership of the Royal College… View more
Kevin Vernooy
Job title: Head of Cardiology
Personal History Prof. Kevin Vernooy is based in Maastricht, The Netherlands, where he works as Head of Cardiology for Maastricht UMC+. Academic History Prof. Kevin Vernooy became a medical doctor in 2003, after completing his studies at Maastricht University. He completed his PhD in 2006 on cardiac resynchronisation therapy at Maastricht University. In 2012, he finished his… View more
Karl-Heinz Kuck
Job title: Medical Director
Prof Karl-Heinz Kuck is the Medical Director at LANS Cardio Hamburg. For many years, he was head of the Department of Cardiology at the Asklepios Klinik St. Georg in Hamburg. In addition, Prof Kuck was President of the European Heart Rhythm Association and President of the German Society for Cardiology. He has earned several prizes for his work, including the Science Prize of the Gertrud Spitz… View more
View from the Thoraxcenter: ACC.24 Late-breaking Science Wrap Up
Author(s): Nicolas M Van Mieghem , Joost Daemen Added: 1 week ago
Unpack ACC.24's Top Trials with View from the Thoraxcenter!Join Prof Nicolas Van Mieghem and Dr Joost Daemen from Erasmus MC, Rotterdam for a deep dive into the late-breaking data presented at ACC.24.In this thought-provoking ACC 2024 wrap-up, delve into the nuances of the most impactful trials, gaining insights into their implications for current practice and future research directions.00:29 -… View more

Standards & Guidelines

Heart Failure
Julia Grapsa
Job title: Consultant Cardiologist
Dr Julia Grapsa has been a Consultant Cardiologist at Guy's and St Thomas' NHS Foundation Trust in London, UK since March 2020, leading the imaging team for tricuspid services. Dr Grapsa is editor-in-chief for JACC Case Reports, and is a fellow for the Royal College of Physicians, the European Society of Cardiology, the American Heart Association, EACVI, the American Society of… View more
Hemodynamic-based Assessment and Management of Cardiogenic Shock
Author(s): Jaime A Hernandez-Montfort , Diana Miranda , Varinder Kaur Randhawa , et al Added: 2 years ago

Heart Failure

MI/ACS
Author(s): Ahmad Younes , Guilherme Ferragut Attizzani , Ankur Kalra Added: 3 years ago
Transcatheter aortic valve replacement (TAVR) is a recent innovation that has transformed the care of patients with symptomatic severe aortic stenosis. It has emerged as an alternative for surgical aortic valve replacement (SAVR) in prohibitive-, high-risk, and more recently, intermediate-risk surgical patients. More than 200,000 TAVRs have been performed in 65 countries around the world.1 As… View more

Vascular Disease and Surgery

Intervention